Norman A W, Nemere I, Muralidharan K R, Okamura W H
Department of Biochemistry, University of California, Riverside 92521.
Biochem Biophys Res Commun. 1992 Dec 30;189(3):1450-6. doi: 10.1016/0006-291x(92)90237-f.
The steroid hormone 1 alpha,25-dihydroxyvitamin-D3 [1 alpha,25(OH)2D3] stimulates biological responses via both genomic mechanisms and nongenomic mechanisms (opening of voltage-gated Ca2+ channels). We report here that 1 beta, 25(OH)2-vitamin-D3 (a) is devoid of activity as an agonist for transcaltachia, (b) is a potent stereospecific antagonist of 1 alpha,25 (OH)2D3 stimulation of the nongenomic transcaltachia response and also (c) has less than 1% the ability of 1 alpha,25(OH)2D3 to bind to the chick intestinal nuclear 1 beta,25(OH)2D3 receptor. We conclude that the membrane response element(s) which generates the nongenomic response of transcaltachia has a different ligand specificity than the classic nuclear 1 alpha, 25(OH)2D3 receptor.
类固醇激素1α,25 - 二羟基维生素D3 [1α,25(OH)2D3] 通过基因组机制和非基因组机制(电压门控Ca2+通道开放)刺激生物学反应。我们在此报告,1β,25(OH)2 - 维生素D3:(a) 作为转钙素激动剂无活性;(b) 是1α,25(OH)2D3刺激非基因组转钙素反应的强效立体特异性拮抗剂;并且(c) 与1α,25(OH)2D3相比,其与鸡肠细胞核1β,25(OH)2D3受体结合的能力不到1%。我们得出结论,产生转钙素非基因组反应的膜反应元件具有与经典核1α,25(OH)2D3受体不同的配体特异性。